Problems of including RWD / RWE data in the justification for registration of a medicinal product
Please, see the report by "Problems of including RWD / RWE data in the justification for registration of a medicinal product", Rozhdestvensky D.A., Eurasian Economic Commission, Head of the Department for Coordination of Work in the Sphere of Circulation of Medicines and Medical Devices, Department of Technical Regulation and Accreditation
On September 16, 2021, the Association of Health Technology Assessment Professionals, the Association of Clinical Pharmacologists, the St. Petersburg Chapter of the International Society for Pharmacoeconomic and Outcomes Research (ISPOR) organized and held the II annual scientific and practical conference with international participation “RWD/RWE – Research Tools of Real-World Clinical Practice Today and Tomorrow”. There were 30 reports presented at the conference. Please, see the report by "Problems of including RWD / RWE data in the justification for registration of a medicinal product", Rozhdestvensky D.A., Eurasian Economic Commission, Head of the Department for Coordination of Work in the Sphere of Circulation of Medicines and Medical Devices, Department of Technical Regulation and Accreditation
The web-site of this journal uses cookies to optimize its performance and design as well as special service to collect and analyze data about pages visitors. By continuing to browse this web-site you agree to use cookies and the above service.